Cx Institutional Moderna, Inc. Transaction History

Cx Institutional

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	BUY	$101.21 - $166.61 $148,879 - $245,083	1,471 Added 49.6%	4,437 $526,000
Q1 2024 Apr 15, 2024	BUY	$85.37 - $115.44 $50,453 - $68,225	591 Added 24.88%	2,966 $316,000
Q4 2023 Jan 12, 2024	BUY	$69.51 - $104.43 $165,086 - $248,021	2,375 New	2,375 $236,000
Q1 2023 May 04, 2023	BUY	$135.66 - $197.02 $135,253 - $196,428	997 Added 80.6%	2,234 $343,000
Q4 2022 Feb 03, 2023	BUY	$118.38 - $210.04 $146,436 - $259,819	1,237 New	1,237 $222,000
Q2 2022 Aug 02, 2022	BUY	$117.13 - $176.59 $7,144 - $10,771	61 New	61 $9,000
Q4 2021 Jan 18, 2022	SELL	$225.82 - $368.51 $2,935 - $4,790	-13 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $2,884 - $6,298	13 New	13 $5,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

Stay updated on Cx Institutional with notifications on news.